On Wednesday Mylan’s CEO will testify about the price hike of EpiPens. Mylan has faced growing backlash from many over the rising cost of EpiPens. The price skyrocketed from $100 to $600 since 2007.

On Wednesday Mylan’s CEO will testify about the price hike of EpiPens.

Mylan has faced growing backlash from many over the rising cost of EpiPens. The price skyrocketed from $100 to $600 since 2007.

Republicans on the finance committee are concerned that Mylan was allowed to inappropriately classify EpiPen as a generic drug, reducing the discounts people get from the government who can't afford the drug.